Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home

Newly Added Patents

About This List
  • This screen lists the current month's NEW ADDITIONS or NEW CHANGES to the patents for drugs listed in the Orange Book.
  • This list will be purged after the Cumulative Supplement to the Orange Book is published on the first day of the next month. All the information listed on this screen is also available by using the other Orange Book search methods, such as searching by Proprietary Name.
  • Patents will remain available in the Orange Book even when they are no longer listed as NEW additions or NEW changes.
Additional Information about Patents
  • Patent information is published on or after the submission date as defined in 21 CFR 314.53(d)(5).
  • Patent listings published prior to August 18, 2003, only identify method-of-use claims. The listed patents may include drug substance and/or drug product claims that are not indicated in the listing.
  • As of December 5, 2016, an NDA holder submitting information on a patent that claims both the drug substance and the drug product (and is eligible for listing on either basis) is required only to specify that it claims either the drug substance or the drug product. Orange Book users should not rely on an Orange Book patent listing, regardless of when first published, to determine the range of patent claims that may be asserted by an NDA holder or patent owner.
145 records returned
Appl No Active Ingredient Proprietary Name Dosage Form Route Strength Patent No Patent Expiration Date Drug Substance Claim Drug Product Claim Patent Use Code Delist Requested Mkt. Status
Appl No Active Ingredient Proprietary Name Dosage Form Route Strength Patent No Patent Expiration Date Drug Substance Claim Drug Product Claim Patent Use Code Delist Requested Mkt. Status
N019430 EPINEPHRINE EPIPEN INJECTABLE INTRAMUSCULAR, SUBCUTANEOUS 0.3MG/DELIVERY 9586010 Sep 11, 2025 DP RX
N019430 EPINEPHRINE EPIPEN JR. INJECTABLE INTRAMUSCULAR, SUBCUTANEOUS 0.15MG/DELIVERY 9586010 Sep 11, 2025 DP RX
N020986 INSULIN ASPART RECOMBINANT NOVOLOG FLEXTOUCH INJECTABLE SUBCUTANEOUS 300 UNITS/3ML (100 UNITS/ML) RE46363 Aug 3, 2026 DP RX
N021148 SOMATROPIN RECOMBINANT NORDITROPIN FLEXPRO INJECTABLE INJECTION 5MG/1.5ML RE46363 Aug 3, 2026 DP RX
N021148 SOMATROPIN RECOMBINANT NORDITROPIN FLEXPRO INJECTABLE INJECTION 10MG/1.5ML RE46363 Aug 3, 2026 DP RX
N021148 SOMATROPIN RECOMBINANT NORDITROPIN FLEXPRO INJECTABLE INJECTION 15MG/1.5ML RE46363 Aug 3, 2026 DP RX
N021148 SOMATROPIN RECOMBINANT NORDITROPIN FLEXPRO INJECTABLE INJECTION 30MG/3ML RE46363 Aug 3, 2026 DP RX
N021536 INSULIN DETEMIR RECOMBINANT LEVEMIR FLEXTOUCH INJECTABLE SUBCUTANEOUS 300 UNITS/3ML (100 UNITS/ML) RE46363 Aug 3, 2026 DP RX
N021936 TIOTROPIUM BROMIDE SPIRIVA RESPIMAT SPRAY, METERED INHALATION EQ 0.00125MG BASE/INH 5964416 Oct 4, 2016 DP RX
N021936 TIOTROPIUM BROMIDE SPIRIVA RESPIMAT SPRAY, METERED INHALATION EQ 0.00125MG BASE/INH 6453795 Dec 5, 2016 DP RX
N021936 TIOTROPIUM BROMIDE SPIRIVA RESPIMAT SPRAY, METERED INHALATION EQ 0.00125MG BASE/INH 6726124 Oct 4, 2016 DP RX
N021936 TIOTROPIUM BROMIDE SPIRIVA RESPIMAT SPRAY, METERED INHALATION EQ 0.00125MG BASE/INH 7104470 Oct 4, 2016 DP RX
N022266 FENTANYL CITRATE ONSOLIS FILM BUCCAL EQ 0.2MG BASE 9597288 Jul 23, 2027 DP U-767 DISCN
N022266 FENTANYL CITRATE ONSOLIS FILM BUCCAL EQ 0.4MG BASE 9597288 Jul 23, 2027 DP U-767 DISCN
N022266 FENTANYL CITRATE ONSOLIS FILM BUCCAL EQ 0.6MG BASE 9597288 Jul 23, 2027 DP U-767 DISCN
N022266 FENTANYL CITRATE ONSOLIS FILM BUCCAL EQ 0.8MG BASE 9597288 Jul 23, 2027 DP U-767 DISCN
N022266 FENTANYL CITRATE ONSOLIS FILM BUCCAL EQ 1.2MG BASE 9597288 Jul 23, 2027 DP U-767 DISCN
N022450 ACETAMINOPHEN OFIRMEV SOLUTION IV (INFUSION) 1GM/100ML (10MG/ML) 9610265 Nov 13, 2028 U-2000 RX
N200327 CEFTAROLINE FOSAMIL TEFLARO POWDER IV (INFUSION) 400MG/VIAL 9629861 Sep 21, 2030 DP RX
N200327 CEFTAROLINE FOSAMIL TEFLARO POWDER IV (INFUSION) 600MG/VIAL 9629861 Sep 21, 2030 DP RX
N200678 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE KOMBIGLYZE XR TABLET, EXTENDED RELEASE ORAL 1GM;EQ 5MG BASE 9339472 Jul 13, 2025 DP RX
N200678 METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE KOMBIGLYZE XR TABLET, EXTENDED RELEASE ORAL 1GM;EQ 2.5MG BASE 9339472 Jul 13, 2025 DP RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8298576 Apr 4, 2028 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8298576 Apr 4, 2028 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8298576 Apr 4, 2028 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8298576 Apr 4, 2028 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8298576 Apr 4, 2028 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8298576 Apr 4, 2028 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8298576 Apr 4, 2028 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8298576 Apr 4, 2028 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8298580 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8298580 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8298580 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8298580 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8298580 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8298580 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8298580 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8298580 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8663683 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8663683 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8663683 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8663683 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8663683 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8663683 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8663683 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8663683 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8877248 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8877248 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8877248 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8877248 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8877248 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8877248 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8877248 Nov 16, 2027 DP U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8877248 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8889191 Nov 16, 2027 U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8889191 Nov 16, 2027 U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8889191 Nov 16, 2027 U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8889191 Nov 16, 2027 U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8889191 Nov 16, 2027 U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8889191 Nov 16, 2027 U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8889191 Nov 16, 2027 U-106 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8889191 Nov 16, 2027 U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8992989 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 8992989 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8992989 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 8992989 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8992989 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 8992989 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8992989 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 8992989 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 9549940 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 9549940 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 9549940 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 9549940 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 9549940 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 9549940 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 9549940 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 9549940 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 9555004 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 25MG 9555004 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 9555004 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 50MG 9555004 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 9555004 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 100MG 9555004 Nov 16, 2027 DP U-1992 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 9555004 Nov 16, 2027 DP U-1675 RX
N201635 TOPIRAMATE TROKENDI XR CAPSULE, EXTENDED RELEASE ORAL 200MG 9555004 Nov 16, 2027 DP U-1992 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.1MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.2MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.4MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.6MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.8MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.2MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.6MG 9289387 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.1MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.2MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.4MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.6MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.8MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.2MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.6MG 9642797 Jan 25, 2027 DP U-55 RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.1MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.2MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.4MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.6MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 0.8MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.2MG 9642844 Jan 25, 2027 DP RX
N202788 FENTANYL SUBSYS SPRAY SUBLINGUAL 1.6MG 9642844 Jan 25, 2027 DP RX
N203313 INSULIN ASPART; INSULIN DEGLUDEC RYZODEG 70/30 SOLUTION SUBCUTANEOUS 90 UNITS/3ML;210 UNITS/3ML (30 UNITS/ML;70 UNITS/ML) RE46363 Aug 3, 2026 DP RX
N203314 INSULIN DEGLUDEC TRESIBA SOLUTION SUBCUTANEOUS 300 UNITS/3ML (100 UNITS/ML) RE46363 Aug 3, 2026 DP RX
N203314 INSULIN DEGLUDEC TRESIBA SOLUTION SUBCUTANEOUS 600 UNITS/3ML (200 UNITS/ML) RE46363 Aug 3, 2026 DP RX
N204485 VASOPRESSIN VASOSTRICT SOLUTION IV (INFUSION) 20UNITS/ML (20UNITS/ML) 9375478 Jan 30, 2035 U-1857 DISCN
N204485 VASOPRESSIN VASOSTRICT SOLUTION IV (INFUSION) 20UNITS/ML (20UNITS/ML) 9375478 Jan 30, 2035 U-1857 RX
N206030 CARBAMAZEPINE CARNEXIV SOLUTION IV (INFUSION) 200MG/20ML (10MG/ML) 9629797 Nov 10, 2028 U-2004 RX
N206030 CARBAMAZEPINE CARNEXIV SOLUTION IV (INFUSION) 200MG/20ML (10MG/ML) 9629797 Nov 10, 2028 U-2005 RX
N206030 CARBAMAZEPINE CARNEXIV SOLUTION IV (INFUSION) 200MG/20ML (10MG/ML) 9629797 Nov 10, 2028 U-2006 RX
N206110 CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE POWDER IV (INFUSION) 50MG/VIAL 9636407 Dec 21, 2032 DP RX
N206110 CASPOFUNGIN ACETATE CASPOFUNGIN ACETATE POWDER IV (INFUSION) 70MG/VIAL 9636407 Dec 21, 2032 DP RX
N206321 LIRAGLUTIDE RECOMBINANT SAXENDA SOLUTION SUBCUTANEOUS 18MG/3ML (6MG/ML) RE46363 Aug 3, 2026 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6149054 Dec 19, 2016 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6149054*PED Jun 19, 2017 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6846413 Aug 28, 2018 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6846413*PED Feb 28, 2019 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6977042 Aug 28, 2018 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6977042*PED Feb 28, 2019 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6988496 Feb 23, 2020 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 6988496*PED Aug 23, 2020 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7284474 Aug 26, 2024 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7284474*PED Feb 26, 2025 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7396341 Oct 10, 2026 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7396341*PED Apr 10, 2027 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7802568 Feb 26, 2019 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7802568*PED Aug 26, 2019 RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7837235 Mar 13, 2028 DP RX
N206756 OLODATEROL HYDROCHLORIDE; TIOTROPIUM BROMIDE STIOLTO RESPIMAT SPRAY, METERED INHALATION EQ 0.0025MG BASE/INH;EQ 0.0025MG BASE/INH 7837235*PED Sep 13, 2028 RX
N207233 MELOXICAM VIVLODEX CAPSULE ORAL 5MG 9649318 Mar 31, 2035 DP RX
N207233 MELOXICAM VIVLODEX CAPSULE ORAL 10MG 9649318 Mar 31, 2035 DP RX
N207917 ADAPALENE; BENZOYL PEROXIDE EPIDUO FORTE GEL TOPICAL 0.3%;2.5% 8445543 Dec 23, 2022 U-1078 RX
N207997 MIDOSTAURIN RYDAPT CAPSULE ORAL 25MG 7973031 Oct 17, 2024 U-2007 RX
N207997 MIDOSTAURIN RYDAPT CAPSULE ORAL 25MG 8222244 Oct 29, 2022 U-2007 RX
N207997 MIDOSTAURIN RYDAPT CAPSULE ORAL 25MG 8575146 Dec 2, 2030 U-2008 RX
N208400 METHOTREXATE SODIUM XATMEP SOLUTION ORAL EQ 2.5MG BASE/ML 9259427 Jan 2, 2033 DP RX
N208583 INSULIN DEGLUDEC; LIRAGLUTIDE XULTOPHY 100/3.6 SOLUTION SUBCUTANEOUS 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML;3.6MG/ML) RE46363 Aug 3, 2026 DP RX
N209777 OXYCODONE HYDROCHLORIDE ROXYBOND TABLET ORAL 5MG 7955619 Aug 12, 2028 DP RX
N209777 OXYCODONE HYDROCHLORIDE ROXYBOND TABLET ORAL 15MG 7955619 Aug 12, 2028 DP RX
N209777 OXYCODONE HYDROCHLORIDE ROXYBOND TABLET ORAL 30MG 7955619 Aug 12, 2028 DP RX

View a list of all patent use codes
View a list of all exclusivity codes

Last Updated May 24, 2017.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English